MOUNJARO: payments to doctors
Payments that named MOUNJARO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $46.3M
- Providers
- 121,525
- Transactions
- 822,927
- Average per transaction
- $56
The per-transaction average — $56 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 121,525 providers the average total is $381, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lilly USA, LLC | $45,995,064 | 99.3% |
| Eli Lilly | $314,991 | 0.7% |
| Eli Lilly Export S.A. Puerto Rico Branch | $21,463 | 0.0% |